Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Trials: Overview01:11

Clinical Trials: Overview

3.1K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.1K
Clinical Trials01:16

Clinical Trials

6.9K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
6.9K
Hazard Ratio01:12

Hazard Ratio

173
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
173
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

151
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
151
Preclinical Development: Overview01:28

Preclinical Development: Overview

4.5K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.5K
Bioequivalence: Overview01:16

Bioequivalence: Overview

1.1K
Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Polymeric Nano Drug Delivery Systems for Overcoming Tumor Microenvironment-Mediated Drug Resistance.

Pharmaceutics·2026
Same author

A novel antibody against CD300c ameliorates cognitive deficits and reduces pathology in the late-stage of APP/PS1 mouse model.

Journal of Alzheimer's disease : JAD·2026
Same author

Barrier-Oriented Design of Next-Generation Polymeric Nanocarriers for Targeted Drug Delivery.

Molecules (Basel, Switzerland)·2026
Same author

The menstrual cycle through the lens of a wearable device: insights into physiology, sleep, and cycle variability.

NPJ digital medicine·2026
Same author

Designing the Thinking: Reimaging Health Informatics via Journey Maps and Personas.

Studies in health technology and informatics·2026
Same author

Exploring the immunological functions of calreticulin 3a from Scomber japonicus (SjCalr3a): insight into antimicrobial defense, cytoprotection, and pro-inflammatory responses.

Fish & shellfish immunology·2026

Related Experiment Video

Updated: Jul 31, 2025

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
07:50

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts

Published on: September 20, 2018

16.0K

Parsable Clinical Trial Eligibility Criteria Representation Using Natural Language Processing.

Jeongeun Kim1,2, Mitchell Izower1,2, Yuri Quintana1,2

  • 1Harvard Medical School, Boston, MA.

AMIA ... Annual Symposium Proceedings. AMIA Symposium
|May 2, 2023
PubMed
Summary

This study introduces a machine learning method to extract clinical trial eligibility criteria from unstructured text. This structured data aims to improve clinical trial recruitment and advance medical research.

Keywords:
Clinical Trial Eligibility CriteriaNatural Language ProcessingStructural Representation

More Related Videos

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

378
Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness
03:14

Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness

Published on: December 6, 2024

643

Related Experiment Videos

Last Updated: Jul 31, 2025

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
07:50

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts

Published on: September 20, 2018

16.0K
Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

378
Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness
03:14

Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness

Published on: December 6, 2024

643

Area of Science:

  • Clinical research informatics
  • Biomedical data science
  • Medical artificial intelligence

Background:

  • Clinical trials are crucial for advancing medical treatments and scientific understanding.
  • Effective clinical trial recruitment relies on precise eligibility criteria.
  • Current methods for defining eligibility criteria in free-text hinder automated recruitment.

Purpose of the Study:

  • To develop a machine learning approach for extracting clinical trial eligibility criteria.
  • To convert unstructured eligibility criteria into a structured, queryable format.
  • To present a standardized JSON-based structure for clinical trial eligibility criteria.

Main Methods:

  • Utilized a machine learning model to process unstructured clinical trial eligibility criteria.
  • Employed descriptive statistics, focusing on medical entity frequency and binary entity relationships.
  • Developed a JSON-based data structure for representing the extracted criteria.

Main Results:

  • Successfully extracted and structured clinical trial eligibility criteria.
  • Demonstrated the feasibility of converting free-text criteria into a queryable format.
  • Proposed a novel JSON schema for standardizing eligibility criteria representation.

Conclusions:

  • Machine learning offers a viable solution to automate the extraction of clinical trial eligibility criteria.
  • Structured eligibility criteria can significantly improve clinical trial recruitment efficiency.
  • The proposed JSON format provides a foundation for standardized clinical trial data representation.